Valziflocept (BAX1810, TAK-752) is a recombinant soluble human FcgammaRIIb receptor that targets Fc and FcgammaR. FcgammaRs bind to and neutralize pathogenic IgG, thereby acting as a decoy or scavenger receptor that reduces the severity of autoimmune diseases. Valziflocept is used in research on autoimmune diseases such as systemic lupus erythematosus (SLE)[1][2][3].
Molekulargewicht:
(19.693 kDa)
Reinheit:
99.00
CAS Nummer:
[1804910-11-9]
Target-Kategorie:
Fc Receptor (FcR)
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten